Tien Liang BioTech Co., Ltd.
TWO: 4127.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Junxiong Guo
- Employees
- 61
- Headquarters
- New Taipei City, Taiwan
- IPO year
- 2007
- Market cap
- NT$1.8B
- Website
- https://www.tlb.com.tw
Loading 4127…
Loading profile data…Frequently asked questions about 4127
What does Tien Liang BioTech Co., Ltd. (4127.TWO) do?
Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese medicine products, such as pills for liver and kidney deficiency, low back pain, sore feet, dizziness, thirst, dry tongue, sore throat, and heel pain, as well as rheumatism, joint pain, traveling pain, wind-cold-d...
Where does 4127.TWO trade?
Tien Liang BioTech Co., Ltd. (4127.TWO) trades on the Taipei Exchange.
What sector is 4127.TWO in?
Tien Liang BioTech Co., Ltd. (4127.TWO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Tien Liang BioTech Co., Ltd.?
Junxiong Guo is the chief executive officer of Tien Liang BioTech Co., Ltd. (4127.TWO).
Where is Tien Liang BioTech Co., Ltd. headquartered?
Tien Liang BioTech Co., Ltd. is headquartered in Taiwan.
Does 4127.TWO pay a dividend?
Yes — Tien Liang BioTech Co., Ltd. (4127.TWO) paid a trailing twelve-month dividend of TWD 0.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4127.TWO go public?
Tien Liang BioTech Co., Ltd. (4127.TWO) completed its initial public offering in 2007.